Glenmede Trust’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$10.5M Sell
1,109,577
-37,143
-3% -$352K 0.06% 345
2024
Q4
$18.9M Sell
1,146,720
-8,719
-0.8% -$144K 0.1% 213
2024
Q3
$17M Sell
1,155,439
-16,295
-1% -$240K 0.08% 256
2024
Q2
$16.3M Buy
1,171,734
+6,742
+0.6% +$93.5K 0.08% 250
2024
Q1
$18.3M Buy
1,164,992
+78,469
+7% +$1.23M 0.09% 231
2023
Q4
$17.6M Sell
1,086,523
-27,868
-3% -$451K 0.09% 220
2023
Q3
$13.7M Sell
1,114,391
-12,490
-1% -$154K 0.08% 260
2023
Q2
$19.5M Buy
1,126,881
+2,270
+0.2% +$39.3K 0.11% 196
2023
Q1
$19.6M Buy
1,124,611
+15,265
+1% +$266K 0.11% 196
2022
Q4
$10.3M Sell
1,109,346
-147,940
-12% -$1.37M 0.06% 325
2022
Q3
$10.8M Buy
1,257,286
+72,615
+6% +$625K 0.07% 300
2022
Q2
$9.65M Buy
1,184,671
+499,788
+73% +$4.07M 0.06% 353
2022
Q1
$8.32M Buy
684,883
+207,370
+43% +$2.52M 0.04% 388
2021
Q4
$16.3M Buy
477,513
+140,124
+42% +$4.78M 0.08% 294
2021
Q3
$16.3M Sell
337,389
-7,635
-2% -$368K 0.08% 268
2021
Q2
$15.6M Sell
345,024
-1,617
-0.5% -$73K 0.08% 273
2021
Q1
$16.7M Sell
346,641
-86,077
-20% -$4.15M 0.09% 252
2020
Q4
$23.3M Sell
432,718
-208,868
-33% -$11.2M 0.13% 191
2020
Q3
$23.7M Sell
641,586
-87,710
-12% -$3.24M 0.14% 169
2020
Q2
$22.6M Sell
729,296
-332,970
-31% -$10.3M 0.14% 180
2020
Q1
$31.1M Hold
1,062,266
0.14% 198
2019
Q4
$31.1M Sell
1,062,266
-141,881
-12% -$4.15M 0.14% 198
2019
Q3
$23K Sell
1,204,147
-97,869
-8% -$1.87K 0.11% 256
2019
Q2
$28.6K Buy
1,302,016
+1,105,970
+564% +$24.3K 0.13% 235
2019
Q1
$4.01K Buy
196,046
+195,161
+22,052% +$3.99K 0.02% 511
2018
Q4
$11 Sell
885
-6,640
-88% -$83 ﹤0.01% 2233
2018
Q3
$114K Buy
+7,525
New +$114K ﹤0.01% 1280